Nitric oxide metabolites and oxidative stress in mild essential hypertension

Clinical Hemorheology and Microcirculation

Volumn 46, Issue 4, 2010, Pages 321-325

  Caimi, G ^a   Mule G ^a   Hopps, E ^a   Carollo, C ^a   Presti, R Lo ^a  

^a UNIVERSITY OF PALERMO   (Italy)

Author keywords

Essential hypertension; lipid peroxidation; NOx; total antioxidant status

Indexed keywords

CHOLESTEROL; GLUCOSE; NITRIC OXIDE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TRIACYLGLYCEROL;

ADULT; ANTIHYPERTENSIVE THERAPY; ANTIOXIDANT ACTIVITY; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE DURATION; ESSENTIAL HYPERTENSION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; LIPID PEROXIDATION; MALE; OXIDATIVE STRESS; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; ANTIOXIDANTS; BLOOD PRESSURE; FEMALE; HUMANS; HYPERTENSION; LIPID PEROXIDATION; MALE; MIDDLE AGED; NITRIC OXIDE; OXIDATIVE STRESS; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

EID: 78650951388     PISSN: 13860291     EISSN: None     Source Type: Journal    
DOI: 10.3233/CH-2010-1360     Document Type: Article

References (33)

1. M.C. Armas-Padilla, M.J. Armas-Hernandez, B. Sosa-Chanache, R. Cammarata, B. Pacheco, J. Guerrero, A.R. Carvajal, R. Hernàndez-Hernàndez, Z.H. Israili and M. Valasco, Nitric oxide and malonildialdehyde, American Journal of Therapeutics 14 (2007), 172-176.
2. G. Caimi, C. Carollo, M. Montana, F. Vaccaro and R. Lo Presti, Elastase, myeloperoxidase, nitric oxide metabolites and oxidative status in subjects with clinical stable chronic renal failure on conservative treatment, Clinical Hemorheology and Microcirculation 43 (2009), 253-258.
3. M. Caner, Y. Karter, H. Uzun, A. Curgunlu, S. Vehid, H. Balci, R. Yucel, I. Güner, A. Kutlu, A. Yaldiran and E. Oztürk, Oxidative stress in human in sustained and white coat hypertension, Internal Journal of Clinical Practice 60 (2006), 1565-1571.
4. M. Cittadino, M. Goncalves de Sousa, J.C. Ugar-Toledo, J.C. Rocha, J.E. Tanus-Santos and H. Moreno Jr., Biochemical endothelial markers and cardiovascular remodelling in refractory arterial hypertension, Clinical and Experimental Hypertension 25 (2003), 25-33.
5. K. Cosby, K.S. Partovi, J.H. Crawford, R.P. Patel, C.D. Reiter, S. Martyr, B.K. Yang, M.A. Waclawiw, G. Zalos, X. Xu, K.T. Huang, H. Shields, D.B. Kim-Shapiro, A.N. Schechter, R.O. Cannon 3rd and M.T. Gladwin, Nitrite reduction to nitric oxide by deoxyhemoglobin vasodilates the human circulation, Nature Medicine 9 (2003), 1498-1505.
6. S. Cottone, G. Mulé, E. Nardi, A. Vadalà, M. Guarneri, C. Briolotta, R. Arsena, A. Palermo, R. Riccobene and G. Cerasola, Relation of C-reactive protein to oxidative stress and to endothelial activation in essential hypertension, American Journal of Hypertension 19 (2006), 313-318.
7. J.L. Cracowski, J.P. Baguet, O. Ormezzano, J. Bessard, F. Stanke-Labesque, G. Bessard and J.M. Mallion, Lipid peroxidation is not increased in patients with untreated mild-to-moderate hypertension, Hypertension 41 (2003), 286-288.
8. C. Di Massimo, P. Scarpelli, N. Di Lorenzo, G. Caimi, F. di Orio and M.G. Ciancarelli, Impaired plasma nitric oxide availability and extracellular superoxide dismutase activity in healthy humans with advancing age, Life Science 78 (2006), 1163-1167. (Pubitemid 43176709)
9. U. Förstermann, H. Kleinert, I. Gath, P. Schwarz, E.I. Closs and N.J. Dun, Expression and expressional control of nitric oxide synthases in various cell types, Advances in Pharmacology 34 (1995), 171-186.
10. M.K. Kashyap, V. Yadav, B.S. Sherawat, S. Jain, S. Kumari, M. Khullar, P.C. Sharma and R. Nath, Different antioxidants status, total antioxidant power and free radicals in essential hypertension, Molecular and Cellular Biochemistry 227 (2005), 89-99.
11. K.Kedziora-Kornatowska, J. Czuczejko, H. Pawluk, T.Kornatowski, J. Motyl, L. Szadujkis-Szadurski, K. Szewczyk-Golec and J. Kedziora, The markers of oxidative stress and activity of the antioxidant system in the blood of elderly patients with essential arterial hypertension, Cellular and Molecular Biology Letters 9 (2004), 635-641.
12. A.M. Kuklinska, B. Mroczko, W.J. Musial, M. Usowicz-Szarynska, R. Sawicki, H. Borowska, M. Knapp and M. Szmitkowski, Diagnostic biomarkers of essential arterial hypertension, International Heart Journal 50 (2009), 341-351.
13. C.A. Kumar and U.N. Das, Lipid peroxides, anti-oxidants and nitric oxide in patients with pre-eclampsia and essential hypertension, Medical Science Monitor 6 (2000), 901-907.
14. Z.Q. Liu, S.M.Wildhirt and H.-H. Zhou, Specificity of inducible nitric oxide synthase inhibitors: Prospects for their clinical therapy, Acta Pharmacologica Sinica 20 (1999), 1052-1056.
15. R. Lo Presti, C. Carollo, M. Montana, B. Canino, A. Catania and G. Caimi, Lipid peroxidation and total antioxidant status in juvenile myocardial infarction, Clinical Hemorheology and Microcirculation 38 (2008), 93-96.
16. N.J. Miller, C. Rice-Evans, M.J. Davies, V. Gopinathan and A. Milner, A novel method for measuring antioxidant capacity and its application to monitoring the antioxidant status in premature neonates, Clinical Science 84 (1993), 407-412.
17. A. Modin, H. Björne, M. Herulf, K. Alving, E. Weitzberg and J.O. Lundberg, Nitrite-derived nitric oxide: A possible mediator of 'acid-metabolic' vasodilation, Acta Physiologica Scandinavica 171 (2001), 9-16.
18. P. Moriel, F.L. Plavnik, M.T. Zanella, M.C. Bertolami and D.S. Abdalla, Lipid peroxidation and antioxidants in hyperlipidemia and hypertension, Biological Research 33 (2000), 105-112.
19. H. Nandeesha, V. Sathiyapriya, Z. Bobby, P. Pavithran, A. Agrawal and N. Selvaraj, Altered oxidant-antioxidant status in non-obese men with moderate essential hypertension, Indian Journal of Medical Sciences 61 (2007), 326-331.
20. S.M. Ouviña, R.D. La Greca, N.L. Zanaro, L. Palmer and B. Sassetti, Endothelial dysfunction, nitric oxide and platelet activation in hypertensive and diabetic type II patients, Thrombosis Research 102 (2001), 107-114.
21. J. Pedro-Botet, M.I. Covas, S. Martìn and J. Rubiés-Prat, Decreased endogenous antioxidant enzymatic status in essential hypertension, Journal of Human Hypertension 14 (2000), 343-345.
22. J. Redòn, M.R. Oliva, C. Tormos, V. Giner, J. Chaves, A. Iradi and G.T. Saez, Antioxidant activities and oxidative stress byproducts in human hypertension, Hypertension 41 (2003), 1096-1101.
23. R. Rodrigo, H. Prat, W. Passalacqua, J. Araya, C. Guichard and J.P. Bächler, Relationship between oxidative stress and essential hypertension, Hypertension Research 30 (2007), 1159-1167.
24. C. Russo, O. Olivieri, D. Girelli, G. Faccini, M.L. Zenari, S. Lombardi and R. Corrocher, Anti-oxidant status and lipid peroxidation in patients with essential hypertension, Journal of Hypertension 16 (1998), 1267-1271.
25. D.V. Simic, J. Mimic-Oka, M. Pljesa-Ercegovac, A. Savic-Radojevic, M. Opacic, D. Matic, B. Ivanovic and T. Simic, Byproducts of oxidative protein damage and antioxidant enzyme activities in plasma of patients with different degrees of essential hypertension, Journal of Human Hypertension 20 (2006), 149-155.
26. P. Subash, K. Premagurumurthy, A. Sarasabharathi and K.M. Cherian, Total antioxidant status and oxidative DNA damage in a South Indian population of essential hypertensives, Journal of Human Hypertension Jan 7 (2010) (Epub ahead of print).
27. S. Turi, A. Friedman, C. Bereczki, F. Papp, J. Kovàcs, E. Karg and I. Németh, Oxidative stress in juvenile essential hypertension, Journal of Hypertension 21 (2003), 145-152.
28. R.M. Touyz and E.L. Schiffrin, Reactive oxygen species in vascular biology: Implications in hypertension, Histochemistry and Cell Biology 122 (2004), 339-352.
29. H. Uzun, Y. Karter, S. Ayden, A. Curgunlu, G. Simşek, R. Yücel, S. Vehiyd, N. Ertürk, A. Kutlu, A. Benian, A. Yaldiran, E. Oztürk and S. Erdine, Oxidative stress in white coat hypertension; role of paraoxonase, Journal of Human Hypertension 18 (2004), 523-528.
30. T. Vyzantiadis, A. Karagiannis, S. Douma, P. Harsoulis, A. Vyzantiadis and C. Zamboulis, Vascular endothelial growth factor and nitric oxide serum levels in arterial hypertension, Clinical and Experimental Hypertension 28 (2006), 603-609.
31. N.C. Ward, J.M. Hodgson, I.B. Puddey, T.A. Mori, L.J. Beilin and K.D. Croft, Oxidative stress in human hypertension: Association with antihypertensive treatment, gender, nutrition, and lifestyle, Free Radical Biology & Medicine 36 (2004), 226-232.
32. J.B. Weinberg, Nitric oxide production and nitric oxide synthase type 2 expression by human mononuclear phagocytes - a review, Molecular Medicine 4 (1998), 557-591.
33. I. Zavaroni, D. Ardigo, P.C. Rossi, A. Zuccarelli, E. Pacetti, L. Monti, P.M. Piatti and G.M. Reaven, Relationship between plasma nitric oxide concentration and insulin resistance in essential hypertension, American Journal of Hypertension 17 (2004), 549-552.